Breast Cancer Res
Volume 5
Suppl 1 |
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Oral presentationClinical breast cancer and estrogenHK Chew UC Davis Cancer Center, Sacramento, California, USA 24 th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models Sacramento, USA. 1-5 November 2003 Breast Cancer Res 2003,
5(Suppl 1):18doi:10.1186/bcr677
| Published: |
31 October 2003 |
Oral presentationEndocrine therapy, targeting estrogen production or the estrogen receptor, is a crucial component in the treatment of breast cancer. This has been recognized for over a century. Ovarian ablation is the oldest form of endocrine therapy, first used in 1896. This presentation will review: the history of endocrine therapy in the treatment of breast cancer; endocrine strategies in premenopausal and postmenopausal women; data on the use of endocrine therapy in early breast cancer; new directions in the endocrine therapy of metastatic breast cancer; and clinical implications of HER2-neu status and endocrine therapy.
| 
on Google Scholar
